BioMarin Pharmaceutical Inc
BMRN· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $136.87M | $128.12M | $113.43M | $97.75M |
| Net Income | -$53.02M | -$5.36M | -$17.65M | $217.33M |
| EPS Diluted | -$0.38 |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.16 |
| $1.68 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.